PE42798A1 - Antagonistas oxadiazol y tiadiazol del receptor muscarinico - Google Patents
Antagonistas oxadiazol y tiadiazol del receptor muscarinicoInfo
- Publication number
- PE42798A1 PE42798A1 PE1997000104A PE00010497A PE42798A1 PE 42798 A1 PE42798 A1 PE 42798A1 PE 1997000104 A PE1997000104 A PE 1997000104A PE 00010497 A PE00010497 A PE 00010497A PE 42798 A1 PE42798 A1 PE 42798A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- antagonists
- muscarinic receptor
- compounds
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I) Y A COMPUESTOS INTERMEDIOS DE FORMULA (II), EN DONDE: R1 ES CICLOALQUILO C3-C7 O ARILO, ENTRE OTROS; R2 ES H O ALQUILO C1-C4; R3 ES ARILO O HETEROARILO; "Y" ES ENLACE DIRECTO, -CH2-, -(CH2)2- o -CH2O-; "X" ES O o S; SIENDO EL COMPUESTO (I) PREFERIDO EL 3-(1-CICLOBUTIL-1-FENIL-1-HIDROXIMETIL)-5-[4-(1-BENCILPIPERIDINIL)]-1,2,4-OXADIAZOL. TAMBIEN SE REFIEREN A LOS PROCEDIMIENTOS DE PREPARACION DE (I), QUE COMPRENDEN: 1) HACER REACCIONAR EL COMPUESTO (II) CON R1MgHal, R1Li o R1CeCl2, o 2) HACER REACCIONAR EL COMPUESTO (III) [DIFERENTE DEL COMPUESTO (I) EN QUE NO PRESENTA EL SUSTITUYENTE -C(R2)-Y-R3] CON: a) Q-CH(R2)-Y-R3, EN DONDE "Q" ES UN GRUPO SALIENTE, EN PRESENCIA DE UN ACEPTOR DE ACIDO, o b) R3-Y-CO-R2, EN PRESENCIA DE UN AGENTE REDUCTOR. LOS COMPUESTOS OBTENIDOS ACTUAN COMO ANTAGONISTAS DEL RECEPTOR MUSCARINICO, SIENDO USADOS EN ENFERMEDADES ASOCIADAS CON LA MOTILIDAD ALTERADA, TALES COMO EL SINDROME DEL INTESTINO IRRITABLE Y LA INCONTINENCIA URINARIA, ADEMAS SON USADOS COMO REFORZADORES DE LA COGNICION EN ENFERMEDADES QUE IMPLICAN DETERIORO DE LA MEMORIA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9603755.1A GB9603755D0 (en) | 1996-02-22 | 1996-02-22 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE42798A1 true PE42798A1 (es) | 1998-08-18 |
Family
ID=10789217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000104A PE42798A1 (es) | 1996-02-22 | 1997-02-14 | Antagonistas oxadiazol y tiadiazol del receptor muscarinico |
Country Status (43)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| GB0510139D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| WO2008017827A2 (en) * | 2006-08-08 | 2008-02-14 | Argenta Discovery Limited | Azole and thiazole derivatives and their uses |
| WO2008023157A1 (en) * | 2006-08-21 | 2008-02-28 | Argenta Discovery Limited | Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| WO2008096093A1 (en) * | 2007-02-06 | 2008-08-14 | Argenta Discovery Ltd. | Oxazole and thiazole derivatives and their uses |
| GB0702414D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | Oxazole and thiazole derivatives and their uses 2 |
| GB0702416D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| BRPI0807004A2 (pt) * | 2007-02-07 | 2014-04-15 | Argenta Discovery Ltd | Sal |
| GB0702382D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New salt |
| GB0702385D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| RU2009133258A (ru) * | 2007-02-15 | 2011-03-20 | Арджента Дискавери Лимитед (Gb) | Гетероциклические производные в качестве ингибиторов мускариновых рецепторов типа мз |
| WO2009098453A1 (en) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
| US8263623B2 (en) | 2008-07-11 | 2012-09-11 | Pfizer Inc. | Triazol derivatives useful for the treatment of diseases |
| WO2010018352A1 (en) * | 2008-08-12 | 2010-02-18 | Argenta Discovery Limited | Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated |
| JP2014065387A (ja) * | 2012-09-25 | 2014-04-17 | Showa Corp | 自動二輪車の車高調整装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| EP0619814A1 (en) * | 1991-12-31 | 1994-10-19 | Fujisawa Pharmaceutical Co., Ltd. | Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| TW360653B (en) * | 1995-03-01 | 1999-06-11 | Janssen Pharmaceutica Nv | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition |
-
1996
- 1996-02-22 GB GBGB9603755.1A patent/GB9603755D0/en active Pending
-
1997
- 1997-01-21 TW TW086100642A patent/TW492961B/zh not_active IP Right Cessation
- 1997-02-03 HN HN1997000020A patent/HN1997000020A/es unknown
- 1997-02-04 ES ES97902337T patent/ES2156357T3/es not_active Expired - Lifetime
- 1997-02-04 EP EP97902337A patent/EP0885218B1/en not_active Expired - Lifetime
- 1997-02-04 DK DK97902337T patent/DK0885218T3/da active
- 1997-02-04 CA CA002247164A patent/CA2247164C/en not_active Expired - Fee Related
- 1997-02-04 SK SK1123-98A patent/SK283461B6/sk unknown
- 1997-02-04 DE DE69704701T patent/DE69704701T2/de not_active Expired - Fee Related
- 1997-02-04 CN CN97192486A patent/CN1089340C/zh not_active Expired - Fee Related
- 1997-02-04 TR TR1998/01644T patent/TR199801644T2/xx unknown
- 1997-02-04 CZ CZ19982678A patent/CZ292650B6/cs not_active IP Right Cessation
- 1997-02-04 NZ NZ331039A patent/NZ331039A/en unknown
- 1997-02-04 AU AU16014/97A patent/AU712230B2/en not_active Ceased
- 1997-02-04 KR KR1019980706534A patent/KR100315934B1/ko not_active IP Right Cessation
- 1997-02-04 AT AT97902337T patent/ATE200899T1/de not_active IP Right Cessation
- 1997-02-04 BR BR9707733A patent/BR9707733A/pt not_active Application Discontinuation
- 1997-02-04 PT PT97902337T patent/PT885218E/pt unknown
- 1997-02-04 WO PCT/EP1997/000525 patent/WO1997030994A1/en active IP Right Grant
- 1997-02-04 IL IL12541397A patent/IL125413A/en not_active IP Right Cessation
- 1997-02-04 US US09/117,556 patent/US5977142A/en not_active Expired - Fee Related
- 1997-02-04 RU RU98117457/04A patent/RU2162848C2/ru not_active IP Right Cessation
- 1997-02-04 PL PL97328633A patent/PL186879B1/pl not_active IP Right Cessation
- 1997-02-04 JP JP52974197A patent/JP3148252B2/ja not_active Expired - Fee Related
- 1997-02-04 HU HU9900501A patent/HUP9900501A3/hu unknown
- 1997-02-13 CO CO97007550A patent/CO4650040A1/es unknown
- 1997-02-14 PE PE1997000104A patent/PE42798A1/es not_active Application Discontinuation
- 1997-02-19 DZ DZ970027A patent/DZ2181A1/fr active
- 1997-02-19 TN TNTNSN97039A patent/TNSN97039A1/fr unknown
- 1997-02-20 AP APAP/P/1997/000930A patent/AP751A/en active
- 1997-02-20 HR HR970098A patent/HRP970098B1/xx not_active IP Right Cessation
- 1997-02-20 AR ARP970100667A patent/AR005916A1/es unknown
- 1997-02-21 MY MYPI97000654A patent/MY129729A/en unknown
- 1997-02-21 ZA ZA971513A patent/ZA971513B/xx unknown
- 1997-02-21 ID IDP970521A patent/ID16642A/id unknown
- 1997-04-02 UA UA98094939A patent/UA61068C2/uk unknown
-
1998
- 1998-07-21 IS IS4803A patent/IS4803A/is unknown
- 1998-08-14 OA OA9800143A patent/OA10838A/en unknown
- 1998-08-19 BG BG102699A patent/BG63971B1/bg unknown
- 1998-08-19 BG BG102699A patent/BG102699A/xx unknown
- 1998-08-21 NO NO19983871A patent/NO313414B1/no not_active IP Right Cessation
- 1998-08-21 YU YU35698A patent/YU35698A/sh unknown
-
1999
- 1999-08-05 HK HK99103379A patent/HK1018274A1/xx not_active IP Right Cessation
-
2001
- 2001-06-13 GR GR20010400885T patent/GR3036032T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE42798A1 (es) | Antagonistas oxadiazol y tiadiazol del receptor muscarinico | |
| AR035842A1 (es) | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo | |
| US20120115859A1 (en) | 3,4,5-substituted piperidines as renin inhibitors | |
| KR970703317A (ko) | 벤조헤테로 고리 유도체 | |
| PE20060712A1 (es) | Compuestos derivados de quinolinamina como moduladores del receptor de quimioquina | |
| AR247213A1 (es) | Preparacion de acido 7-¡(1-carboxi-3-fenilpropil)amino¿-3,4,6,7,8,12b-octahidro-6-oxopirido ¡2,1-a¿ o hexahidro-6-oxo-1h(1,4-tiazino¡3,4-a¿¡2¿-benzazepin-4-carboxilico, agentes hipertensivos. | |
| PE51097A1 (es) | Nuevos taxoides, su preparacion y composiciones farmaceuticas que los contienen | |
| PE20050525A1 (es) | Derivados de pirazol sustituido y compuestos relacionados como antagonistas del receptor de bradiquinina b1 | |
| PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
| PE20010931A1 (es) | Oxazolidinonas que tienen la funcion de una sulfoximina | |
| JPS55164678A (en) | Novel cyclic imidazolecyanoguanidine | |
| PE62396A1 (es) | Derivado de indol | |
| KR890006647A (ko) | 옥사디아졸-알킬-푸린 유도체류 | |
| PE17598A1 (es) | Quinolinas | |
| DE3664912D1 (en) | 5-(azolyloxyphenylcarbamoyl)-barbituric acid derivatives as active agents in anthelmics | |
| ES2079469T3 (es) | (pirrolidin-2-ona-l-il) acetamidas como mejoradores de aprendimiento y memoria y composiciones farmaceuticas que las comprenden. | |
| ATE161842T1 (de) | Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten | |
| HUT48622A (en) | Process for producing hydrogenated 1-(benzoxacycloalkyl)-pyridinecarboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
| NO20054794L (no) | 7 ([1, 4] dioksan-2-yl)-benzotiazolderivater som adenosinreseptorligander | |
| KR930021202A (ko) | 다찌키닌 수용체 길항제, 이소퀴놀론 및 이의 제조방법 | |
| CA2212893C (en) | Prokinetic oxadiazoles | |
| PE20020600A1 (es) | Heteroaromatos como inhibidores de la 2,3-oxidoescualeno-lanosterol ciclasa | |
| AU695034B2 (en) | Condensed indole derivatives as 5-HT4-receptor antagonists | |
| PE20001463A1 (es) | Nuevos derivados de piperidina, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen | |
| AR011997A1 (es) | Complejo basado en un compuesto de organosilicio y una composicion farmaceutica o cosmetica que lo incluye. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |